Our Research

Research
Houston Methodist COVID-19 Research Thumbnail
Coronavirus Disease 2019 (COVID-19) Research

Houston Methodist researchers are studying the novel coronavirus disease 2019. Read more...

At Houston Methodist, fostering innovations with the potential for clinical application is at the very heart of what we do. Our interdisciplinary teams of clinicians and researchers are committed to streamlining the process of translating discoveries into treatments and cures for our patients.

 

Learn more about how we are delivering on our commitment to leading medicine from the earliest phase of discovery in a lab to the testing new drugs or therapies in clinical trials.

 

Our Annual Report



Novel medical technology for craniomaxillofacial surgery receives FDA clearance for market

Doctor using AnatomicAligner, a new FDA-approved Methodist-built software program, on an iPad.

Houston Methodist recently reached a major milestone, receiving U.S. Food and Drug Administration (FDA) 510(k) clearance to market the AnatomicAligner, a novel, comprehensive software program used to improve planning for craniomaxillofacial (CMF) surgeries. Learn more>

Eamonn Quigley, MD, Receives Master of World Congress of Gastroenterology Award

Eamonn Quigley, MD, David M. Underwood Chair of Medicine in Digestive Disorders and director of the Lynda K. and David M. Underwood Center for Digestive Disorders, received the 2019 Master of the World Gastroenterology Organization Award. Learn more>

Remote-Controlled Drug Delivery Implant May Help Chronic Disease Management

nano device

Houston Methodist scientists led by Alessandro Grattoni, PhD, successfully delivered dosages of chronic disease medications using a nanochannel delivery system controlled remotely via Bluetooth technology. Learn More>

 

Novel Insights Into Cholesterol May Lead to New Therapies for Heart Disease

zebrafish

Scientists at Houston Methodist, led by Longhou Fang, PhD, discovered what makes white blood cell counts spike in individuals who have high cholesterol, possibly leading to new therapies for heart disease. Learn more>

Latest News

Wednesday, May 13, 2020 Study finds COVID plasma therapy safe, with 76% patients improving
The country’s first convalescent plasma transfusion trial results have been published and show 19 out of 25 patients improved with the treatment, and 11 were discharged from the hospital. On March 28, Houston Methodist became the first academic medical center in the nation to transfuse plasma from r...
Read more
Live Chat Available